Literature DB >> 15249980

Radiological placement of chest ports in pediatric oncology patients.

Barbaros E Cil1.   

Abstract

A single center's procedural and follow-up results of radiological chest port placement in pediatric oncology patients are presented. Between July 2002 and December 2003, 37 children (20 boys, 17 girls; age range, 4 months to 16 years; mean 6.7 years) underwent chest port placement. All patients received only one port through the internal jugular vein access, and all of the implantations were performed in the interventional radiology suite. Our database and electronic charts were retrospectively reviewed to obtain follow-up data. All chest ports were successfully implanted. The mean catheter life was 223 days (range: 15-450 days), with a total of 8,258 catheter days. Twenty-eight ports are still in use, four patient deceased, one port was prematurely removed because of a late infection, and four patients were lost to follow-up. Infection rate was 2.7% (0.12/1,000 catheter days). Malfunction due to partial catheter thrombosis and fibrin sheath formation was observed in three patients (8.1% or 0.36/1,000 catheter days), and all were relieved with rt-TPA dwell. None of the ports were revised or removed because of blockage, malposition or difficulty accessing the port. The peri-procedural complication rate was 0%. Chest ports in children can be inserted in interventional radiology suites under imaging guidance with high rates of technical success. The rates of infection and complications are comparable to that of surgically placed ports.

Entities:  

Mesh:

Year:  2004        PMID: 15249980     DOI: 10.1007/s00330-004-2380-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Repositioning of malpositioned or flipped central venous catheters.

Authors:  A Thalhammer; V Jacobi; J Balzer; T J Vogl
Journal:  Eur Radiol       Date:  2001-10-24       Impact factor: 5.315

2.  Radiologic placement of subcutaneous infusion chest ports for long-term central venous access.

Authors:  B Funaki; G X Szymski; C A Hackworth; J D Rosenblum; R Burke; T Chang; J A Leef
Journal:  AJR Am J Roentgenol       Date:  1997-11       Impact factor: 3.959

3.  Radiologic placement of a low profile implantable venous access port in a pediatric population.

Authors:  J L Nosher; L J Bodner; L J Ettinger; R L Siegel; C Gribbin; J Asch; R A Drachtman
Journal:  Cardiovasc Intervent Radiol       Date:  2001-11-08       Impact factor: 2.740

4.  Superiority of the internal jugular over the subclavian access for temporary dialysis.

Authors:  G E Cimochowski; E Worley; W E Rutherford; J Sartain; J Blondin; H Harter
Journal:  Nephron       Date:  1990       Impact factor: 2.847

5.  Successful systemic fibrinolysis in permanent hemodialysis catheter obstruction.

Authors:  K Vogt; U Tillmann; A Blumberg
Journal:  Nephron       Date:  1987       Impact factor: 2.847

6.  Totally implantable central venous access devices for paediatric oncology patients.

Authors:  F D Munro; P M Gillett; J C Wratten; M P Shaw; A Thomas; G A MacKinlay; W H Wallace
Journal:  Med Pediatr Oncol       Date:  1999-10

7.  Totally implanted device for venous access. Experience in tumour patients.

Authors:  H Starkhammar; M Bengtsson
Journal:  Acta Radiol Oncol       Date:  1985 Mar-Apr

8.  Comparison of delayed complications of central venous catheters placed surgically or radiologically in pediatric oncology patients.

Authors:  Tavis J Basford; Dan Poenaru; Mariana Silva
Journal:  J Pediatr Surg       Date:  2003-05       Impact factor: 2.545

9.  Radiologic placement of long-term subcutaneous venous access ports in children.

Authors:  J J Crowley; J K Pereira; L S Harris; C J Becker
Journal:  AJR Am J Roentgenol       Date:  1998-07       Impact factor: 3.959

10.  Catheter-induced lesions of the right side of the heart. A one-year prospective study of 141 autopsies.

Authors:  B S Ducatman; J C McMichan; W D Edwards
Journal:  JAMA       Date:  1985-02-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.